China regulatory change is still a concern unfortunately. I think company get confused as well.
China infant formula regulatory environment • Monitoring of the regulatory environment in China for further changes and clarification remains an ongoing focus for the Company.
Especially the wording about English label product 'Detailed implementation plans to follow'.This is in line with Citi's latest comment that IF may not be classified as PE goods via E-commerce platform.
I feel sorry for Chinese Governments' inconsistency.
- Forums
- ASX - By Stock
- A2M
- Ann: Investor presentation
Ann: Investor presentation, page-5
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B |
Open | High | Low | Value | Volume |
$4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10795 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.83 | 5662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 26112 | 4.800 |
5 | 8198 | 4.790 |
4 | 2409 | 4.780 |
2 | 4629 | 4.770 |
6 | 10700 | 4.760 |
Price($) | Vol. | No. |
---|---|---|
4.840 | 6237 | 1 |
4.850 | 303 | 1 |
4.930 | 10000 | 1 |
4.950 | 2000 | 1 |
4.990 | 6521 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online